By Editor , 18 September 2026
GBM Signs LOI with LiBEST for Ex-China Graphite Anode Supply

Toronto – September 17, 2026 -- Global Battery Materials Corp. (GBM) has signed a non-binding Letter of Intent with South Korean battery manufacturer LiBEST to evaluate and potentially commercially supply natural graphite, coated spherical purified graphite (CSPG), and other anode materials sourced and processed entirely outside China.

By Editor , 18 September 2026
Yuyu Pharma Expands Solar Capacity to 1MW, Cuts Grid Reliance 30%

Seoul, South Korea – September 17, 2026 -- Yuyu Pharma has completed an 869-kilowatt (kW) solar installation at its Korean manufacturing facility, lifting total on-site solar capacity to approximately 1 megawatt (MW) and covering more than 30% of the plant's electricity needs.

By Editor , 17 September 2026
RYBREVANT Combo Extends Survival to 34.3 Months in Lung Cancer Trial

Seoul – September 16, 2026 -- Johnson & Johnson reported that its RYBREVANT (amivantamab-vmjw) plus chemotherapy combination extended median overall survival to 34.3 months in patients with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer, compared with 27.9 months for chemotherapy alone, according to final data from the Phase 3 PAPILLON study.

By Editor , 17 September 2026
Hyundai Motor Group Activates Data Flywheel for Autonomous Driving Push

Seoul – September 16, 2026 -- Hyundai Motor Group has put its "Data Flywheel" system into full operation, converting real-world driving data from an annual fleet of 7 million vehicles sold across the Group into continuous AI training and validation cycles for autonomous driving technology.

By Editor , 17 September 2026
SystImmune's Iza-bren Hits Phase 3 Dose in Global Lung Cancer Trial

Seoul – September 12, 2026 -- SystImmune, Inc. announced that new global Phase 1 data support 2.5 mg/kg D1D8 Q3W as the recommended Phase 3 dose for iza-bren (izalontamab brengitecan), a bispecific EGFRxHER3 antibody drug conjugate, in previously treated EGFR-mutated metastatic non-small cell lung cancer (NSCLC).

By Editor , 17 September 2026

Seoul -- September 9, 2026 -- MegazoneCloud has begun system development on 'Hanmi Q-Agent,' an AI agent designed to cut Hanmi Pharmaceutical's quality assurance document workload by more than 40%, with build work starting September 7.

By Editor , 16 September 2026
HD Hyundai to Invest $780M in New Ulsan Engine, SMR Plants

Seoul, South Korea – September 15, 2026 -- HD Hyundai Heavy Industries will invest a combined KRW 1.0722 trillion to build a new land-based power generation engine plant and a dedicated small modular reactor (SMR) equipment facility, both in Ulsan, as it races to capture surging power demand from AI data centers.

By Editor , 13 September 2026
Ceva, LG Electronics Combine UWB Tech, Land Major US Chipmaker Client

Rockville, Md. and Seoul, South Korea – September 13, 2026 -- Ceva, Inc. (NASDAQ: CEVA) and LG Electronics have secured a major U.S. semiconductor company as a customer for a jointly developed Ultra-Wideband (UWB) solution, marking commercial validation for the two-company collaboration announced today.

By Editor , 13 September 2026
SK keyfoundry Locks Elmos Into Wafer Supply Deal Through 2037

Seoul – September 13, 2026 -- SK keyfoundry has signed a long-term wafer supply agreement with Elmos Semiconductor SE that guarantees production capacity through 2037, extending an 18-year partnership between the Korean 8-inch foundry and the German automotive chipmaker.

The deal, signed during a ceremony in Frankfurt am Main, shifts the two companies' collaboration from 350nm to 130nm process technology, marking the first major node transition in nearly two decades of cooperation.

By Editor , 13 September 2026
DB HiTek Completes 8-Inch 1,200V SiC MOSFET Reliability Qualification

Seoul – September 12, 2026 -- DB HiTek has completed reliability qualification for its 1,200 V silicon carbide (SiC) MOSFET process on 8-inch (200 mm) wafers, establishing what it calls the world's first complete 8-inch SiC foundry process flow. The South Korean pure-play foundry targets volume production in 2027.